RNA–RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection

Author:

Zhang Song1ORCID,Amahong Kuerbannisha2,Zhang Chenyang2,Li Fengcheng2,Gao Jianqing2,Qiu Yunqing3,Zhu Feng2ORCID

Affiliation:

1. College of Pharmaceutical Sciences in Zhejiang University, and the First Affiliated Hospital of Zhejiang University School of Medicine, China

2. College of Pharmaceutical Sciences in Zhejiang University, China

3. First Affiliated Hospital in Zhejiang University, China

Abstract

Abstract Some studies reported that genomic RNA of SARS-CoV-2 can absorb a few host miRNAs that regulate immune-related genes and then deprive their function. In this perspective, we conjecture that the absorption of the SARS-CoV-2 genome to host miRNAs is not a coincidence, which may be an indispensable approach leading to viral survival and development in host. In our study, we collected five datasets of miRNAs that were predicted to interact with the genome of SARS-CoV-2. The targets of these miRNAs in the five groups were consistently enriched immune-related pathways and virus-infectious diseases. Interestingly, the five datasets shared no one miRNA but their targets shared 168 genes. The signaling pathway enrichment of 168 shared targets implied an unbalanced immune response that the most of interleukin signaling pathways and none of the interferon signaling pathways were significantly different. Protein–protein interaction (PPI) network using the shared targets showed that PPI pairs, including IL6-IL6R, were related to the process of SARS-CoV-2 infection and pathogenesis. In addition, we found that SARS-CoV-2 absorption to host miRNA could benefit two popular mutant strains for more infectivity and pathogenicity. Conclusively, our results suggest that genomic RNA absorption to host miRNAs may be a vital approach by which SARS-CoV-2 disturbs the host immune system and infects host cells.

Funder

National Natural Science Foundation of China

Key Research and Development Program of Zhejiang Province

Natural Science Foundation of Zhejiang Province

Fundamental Research Fund for Central Universities

Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare

Information Technology Center of Zhejiang University

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

Reference88 articles.

1. One year of SARS-CoV-2 evolution;Wu;Cell Host Microbe,2021

2. Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs;Li;Brief Bioinform,2020

3. Databases for the targeted COVID-19 therapeutics;Wang;Br J Pharmacol,2020

4. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics;Wang;Nucleic Acids Res,2020

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3